Free tool
Medical devices stocks
We cover 64 companies grouped under the Medical devices theme. The median market value in the group is $14.08B. Across the group, the median move over the past trading day is −0.12%. 69% of the 62 with a 200-day average trade above it. Price change over the past year runs from −24.7% to +65.6% across the middle 80 percent of the group, with a median of +2.0%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
64 of 349 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| ABTT34.SA | Abbott Laboratories | $199.23B | Large cap | −16.35% |
| ABT | Abbott Laboratories | $198.74B | Large cap | −11.83% |
| SYK.DE | Stryker Corporation | $126.78B | Large cap | +34.90% |
| SYK | Stryker Corporation | $126.45B | Large cap | −15.52% |
| MDT | Medtronic plc | $117.78B | Large cap | +2.29% |
| 2M6.DE | Medtronic plc | $117.57B | Large cap | +2.65% |
| B1SX34.SA | Boston Scientific Corporation | $70.04B | Large cap | −89.24% |
| BSX | Boston Scientific Corporation | $69.81B | Large cap | −54.50% |
| BSX.DE | Boston Scientific Corporation | $69.12B | Large cap | −53.11% |
| EWL.DE | Edwards Lifesciences Corporation | $52.39B | Large cap | +11.65% |
| EW | Edwards Lifesciences Corporation | $52.32B | Large cap | +12.21% |
| BOX.DE | Becton, Dickinson and Company | $51.84B | Large cap | +1.73% |
| BDX | Becton, Dickinson and Company | $51.81B | Large cap | +25.97% |
| B1DX34.SA | Becton, Dickinson and Company | $51.78B | Large cap | −113.87% |
| SHL.DE | Siemens Healthineers AG | $51.23B | Large cap | −14.18% |
| E1WL34.SA | Edwards Lifesciences Corporation | $47.29B | Large cap | −4.72% |
| MDLN | Medline Inc. | $46.53B | Large cap | −13.07% |
| RMD | ResMed Inc. | $34.13B | Large cap | −15.77% |
| RMD.AX | ResMed Inc. | $34.05B | Large cap | −24.75% |
| GEHC | GE HealthCare Technologies Inc. | $33.35B | Large cap | −1.15% |
| PHG | Koninklijke Philips N.V. | $26.38B | Large cap | +1.27% |
| PHI1.DE | Koninklijke Philips N.V. | $26.37B | Large cap | +3.22% |
| WST | West Pharmaceutical Services, Inc. | $24.63B | Large cap | +42.61% |
| 4543.T | Terumo Corporation | $23.67B | Large cap | −2.68% |
| STE | STERIS plc | $23.09B | Large cap | −4.41% |
| ZBH | Zimmer Biomet Holdings, Inc. | $19.34B | Large cap | −4.32% |
| Z1BH34.SA | Zimmer Biomet Holdings, Inc. | $18.07B | Large cap | −5.04% |
| COLO-B.CO | Coloplast A/S | $15.96B | Large cap | −20.60% |
| CBHD.DE | Coloplast A/S | $15.94B | Large cap | +7.91% |
| SOLV | Solventum Corporation | $15.58B | Large cap | +25.57% |
| FPH.AX | Fisher & Paykel Healthcare Corporation Limited | $15.44B | Large cap | +11.27% |
| 7733.T | Olympus Corporation | $14.46B | Large cap | +27.06% |
| BAX | Baxter International Inc. | $13.70B | Large cap | +8.90% |
| B1AX34.SA | Baxter International Inc. | $13.60B | Large cap | +3.61% |
| PEN | Penumbra, Inc. | $12.72B | Large cap | +21.02% |
| SNN | Smith & Nephew plc | $12.23B | Large cap | −19.49% |
| SN.L | Smith & Nephew plc | $12.18B | Large cap | −22.42% |
| GMED | Globus Medical, Inc. | $11.16B | Large cap | +35.10% |
| DEMANT.CO | Demant A/S | $9.36B | Mid cap | +17.12% |
| WDH1.DE | Demant A/S | $9.33B | Mid cap | −5.53% |
| 7747.T | Asahi Intecc Co., Ltd. | $6.68B | Mid cap | +53.99% |
| COH.AX | Cochlear Limited | $6.39B | Mid cap | −53.79% |
| CTEC.L | Convatec Group PLC | $6.01B | Mid cap | −1.95% |
| T1FX34.SA | Teleflex Incorporated | $6.00B | Mid cap | +0.29% |
| TFX | Teleflex Incorporated | $5.88B | Mid cap | +8.06% |
| MMSI | Merit Medical Systems, Inc. | $5.44B | Mid cap | −0.28% |
| HAE | Haemonetics Corporation | $4.85B | Mid cap | +93.71% |
| ICUI | ICU Medical, Inc. | $4.49B | Mid cap | +41.83% |
| LIVN | LivaNova PLC | $4.41B | Mid cap | +41.56% |
| OBCK.DE | Ottobock SE & Co. KGaA | $4.40B | Mid cap | +0.68% |
| ITGR | Integer Holdings Corporation | $4.25B | Mid cap | +15.84% |
| ANN.AX | Ansell Limited | $4.17B | Mid cap | +18.41% |
| IRTC | iRhythm Holdings, Inc. | $4.06B | Mid cap | −29.83% |
| PLSE | Pulse Biosciences, Inc. | $3.43B | Mid cap | +203.47% |
| TMDX | TransMedics Group, Inc. | $3.19B | Mid cap | −21.43% |
| ASKER.ST | Asker Healthcare Group AB (publ) | $2.99B | Mid cap | −24.65% |
| AMBU-B.CO | Ambu A/S | $2.69B | Mid cap | −19.13% |
| AXGN | AxoGen, Inc. Common Stock | $2.68B | Mid cap | +219.58% |
| DRW3.DE | Drägerwerk AG & Co. KGaA | $2.45B | Mid cap | +70.53% |
| ATRC | AtriCure, Inc. | $2.45B | Mid cap | +29.14% |
| UFPT | UFP Technologies, Inc. | $2.36B | Mid cap | +41.94% |
| BFLY | Butterfly Network, Inc. | $2.30B | Mid cap | +450.32% |
| ESTA | Establishment Labs Holdings Inc. | $2.15B | Mid cap | +70.71% |
| 6960.T | Fukuda Denshi Co., Ltd. | $2.02B | Mid cap | +79.12% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.